1. Date of download: 6/28/2016 From: Effects of Blood Pressure Reduction in Mild Hypertension: A Systematic Review and Meta-analysis Ann Intern Med. 2015;162(3):184-191. doi:10.7326/M14-0773 Summary of evidence search and selection. BPLTTC = Blood Pressure Lowering Treatment Trialists' Collaboration. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

2. Date of download: 6/28/2016 From: Effects of Blood Pressure Reduction in Mild Hypertension: A Systematic Review and Meta-analysis Ann Intern Med. 2015;162(3):184-191. doi:10.7326/M14-0773 Main treatment effects. The difference in average achieved blood pressure between active and control groups in the BPLTTC studies was 3.6/2.4 mm Hg. ABCD = Appropriate Blood Pressure Control in Diabetes; ACEI = angiotensin-converting enzyme inhibitor; ADVANCE = Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation; ANBP = Australian National Blood Pressure Study; BENEDICT = Bergamo Nephrologic Diabetes Complications Trial; BPLTTC = Blood Pressure Lowering Treatment Trialists' Collaboration; CCB = calcium-channel blocker; CVD = cardiovascular disease; DIABHYCAR = Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril; H = hypertensive sample; MRC = Medical Research Council Trial of Treatment of Mild Hypertension; N = normotensive sample; NA = not applicable; OR = odds ratio; PART-2 = Prevention of Atherosclerosis with Ramipril; PREVEND IT = Prevention of Renal and Vascular End-Stage Disease Intervention Trial; SCAT = Simvastatin/Enalapril Coronary Atherosclerosis Trial; UKPDS = U.K. Prospective Diabetes Study; VA-NHLBI = Veterans Administration-National Heart, Lung, and Blood Institute Feasibility Trial. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

3. Date of download: 6/28/2016 From: Effects of Blood Pressure Reduction in Mild Hypertension: A Systematic Review and Meta-analysis Ann Intern Med. 2015;162(3):184-191. doi:10.7326/M14-0773 Treatment effects in subgroups. Analyses based on BPLTTC status, BP-lowering drugs, and diabetes included all trials; those based on age, sex, and CVD risk included only BPLTTC trials. Data on heart failure and cardiovascular deaths were available only in the BPLTTC trials. BP = blood pressure; BPLTTC = Blood Pressure Lowering Treatment Trialists' Collaboration; CVD = cardiovascular disease; OR = odds ratio. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians

4. Date of download: 6/28/2016 From: Effects of Blood Pressure Reduction in Mild Hypertension: A Systematic Review and Meta-analysis Ann Intern Med. 2015;162(3):184-191. doi:10.7326/M14-0773 Risk of bias within studies. Plus sign denotes low risk. Minus sign denotes high risk. Question mark denotes unclear risk. ABCD = Appropriate Blood Pressure Control in Diabetes; ADVANCE = Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation; ANBP = Australian National Blood Pressure Study; BENEDICT = Bergamo Nephrologic Diabetes Complications Trial; DIABHYCAR = Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril; H = hypertensive sample; MRC = Medical Research Council Trial of Treatment of Mild Hypertension; N = normotensive sample; PART-2 = Prevention of Atherosclerosis with Ramipril; PREVEND IT = Prevention of Renal and Vascular End-Stage Disease Intervention Trial; SCAT = Simvastatin/Enalapril Coronary Atherosclerosis Trial; UKPDS = U.K. Prospective Diabetes Study; VA-NHLBI = Veterans Administration-National Heart, Lung, and Blood Institute Feasibility Trial. Figure Legend: Copyright © American College of Physicians. All rights reserved.American College of Physicians